Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review Ad Meta-Analysis of Randomized Controlled Trials.

Fouad JaberMohammed AyyadSaqr AlsakarnehTala AlsharaehAhmed-Jordan SalahatMohammad JaberManesh Kumar GangwaniYazan AbboudIslam MohamedHassam AliYassine KilaniFrancis A FarrayeJana G Hashash

Published in: American journal of therapeutics (2024)

Targeting IL-23 demonstrates efficacy and safety for inducing and maintaining clinical and endoscopic remission in moderate-to-severe UC patients.

Keyphrases

ulcerative colitis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
systematic review
peritoneal dialysis
prognostic factors
early onset
cancer therapy
rheumatoid arthritis
drug delivery